NCNA NuCana
- 4.0000
- +0.1900+4.99%
- 4.1000
- +0.1000+2.50%
NuCana News
NuCana | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NuCana | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NuCana | F-6 POS: Post-effective amendment to a F-6EF registration
NuCana | 424B5: Prospectus
NuCana | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NuCana | 20-F: Registration statement / Annual report / Transition report
NuCana | 6-K: Report of foreign private issuer (related to financial reporting)
NuCana | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dr. James I. Healy (“Healy”)(11.9%),Sofinnova Venture Partners VIII, L.P. (“SVP VIII”)(8.5%), etc.
NuCana | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hugh S. Griffith(11.0%)
NuCana | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(6.98%)
NuCana | 6-K: Report of foreign private issuer (related to financial reporting)
NuCana | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NuCana | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NuCana | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NuCana | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NuCana | 6-K: Report of foreign private issuer (related to financial reporting)
NuCana | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NuCana | 6-K: Report of foreign private issuer (related to financial reporting)
NuCana | 6-K: Report of foreign private issuer (related to financial reporting)
NuCana | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
